EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Beyond Analgesia: Psychobiotics as an Adjunctive Approach to Pain Management in Gastrointestinal Oncology—A Post Hoc Analysis from the ProDeCa Study

Georgios Tzikos iD, Alexandra-Eleftheria Menni, Helen Theodorou, Eleni Chamalidou, Ioannis M Theodorou iD, George Stavrou iD, Anne D Shrewsbury, Aikaterini Amaniti, Anastasia Konsta, Joulia K Tsetis, Vasileios Grosomanidis, Katerina Kotzampassi iD

Nutrients · 2025

DOI: 10.3390/nu17172751 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Nutrients, 2025. Verfasst von Georgios Tzikos und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Aristotle University of Thessaloniki, 54636 Thessaloniki, Greece. Hauptthemen laut MEDLINE: Gastrointestinal Neoplasms, Pain Management, Probiotics, Cancer Pain. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 92 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Pain is a multifaceted and debilitating symptom in patients with gastrointestinal cancer, especially those undergoing surgical resection followed by chemotherapy. The interplay between inflammatory, neuropathic, and psychosocial components often renders conventional analgesia insufficient. Psychobiotics—probiotic strains with neuroactive properties—have recently emerged as potential modulators of pain perception through neuroimmune and gut–brain axis pathways.

Methods

This post hoc analysis is based on the ProDeCa randomized, placebo-controlled trial, which originally aimed to assess the psychotropic effects of a four-strain psychobiotic formulation in postoperative gastrointestinal cancer patients receiving chemotherapy. In the current analysis, we evaluated changes in pain perception among non-depressed and depressed participants, who received either psychobiotics or placebo, along with standard analgesic regimes. Pain was assessed at baseline, after a month of treatment, and at follow-up, 2 months thereafter, using the Short-Form McGill Pain Questionnaire (SF-MPQ), capturing both sensory and affective components, as well as with the Present Pain Intensity and the VAS scores.

Results

Psychobiotic-treated participants—particularly the non-depressed ones—exhibited a significant reduction in both quantitative and qualitative pain indices over time compared with placebo-treated ones. Improvements were noted in total pain rating index scores, sensory and affective subscales, and present pain intensity. These effects were sustained up to 2 months after intervention. In contrast, placebo groups demonstrated worsening in pain scores, probably influenced by ongoing chemotherapy and disease progression. The analgesic effect was less pronounced but still observable in the subgroup with symptoms of depression.

Conclusions

Adjunctive psychobiotic therapy appears to beneficially modulate pain perception in gastrointestinal oncology patients receiving chemotherapy, with the most pronounced effects being in non-depressed individuals. These findings suggest psychobiotics as a promising non-opioid add-on for comprehensive cancer pain management and support further investigation in larger pain-targeted trials.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal NeoplasmsPain ManagementProbioticsCancer PainHumansFemaleMaleMiddle AgedPain MeasurementAgedAdultPain PerceptionAnalgesiaTreatment Outcome

Stichwörter der Autor:innen

McGill Pain Questionnaireadjunctive therapycancer painchemotherapygastrointestinal cancergut–brain axisnon-opioid analgesiapost hoc analysispsychobiotics

Autor:innen und Institutionen

  • Department of Surgery, Aristotle University of Thessaloniki, 54636 Thessaloniki, Greece.
  • Department of Sociology, School of Social Sciences, University of Crete, 74100 Rethymno, Greece.
  • Outpatient Surgical Oncology Unit, Chemotherapy Department, AHEPA University Hospital, Aristotle University of Thessaloniki, 54636 Thessaloniki, Greece.
  • Hellenic Institute for the Study of Sepsis (HISS), 11528 Athens, Greece.
  • Department of Surgery, 417 NIMTS (Army Share Fund Hospital), 11521 Athens, Greece.
  • Department of Anesthesiology and Intensive Care, School of Medicine, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece.

ORCID-Profile: Georgios Tzikos, Ioannis M Theodorou, George Stavrou, Katerina Kotzampassi

Zitieren

APA

Tzikos, G., Menni, A. E., Theodorou, H., Chamalidou, E., Theodorou, I. M., Stavrou, G., Shrewsbury, A. D., Amaniti, A., Konsta, A., Tsetis, J. K., Grosomanidis, V., & Kotzampassi, K. (2025). Beyond Analgesia: Psychobiotics as an Adjunctive Approach to Pain Management in Gastrointestinal Oncology—A Post Hoc Analysis from the ProDeCa Study. Nutrients. https://doi.org/10.3390/nu17172751

Vancouver

Tzikos G, Menni AE, Theodorou H, Chamalidou E, Theodorou IM, Stavrou G, et al. Beyond Analgesia: Psychobiotics as an Adjunctive Approach to Pain Management in Gastrointestinal Oncology—A Post Hoc Analysis from the ProDeCa Study. Nutrients. 2025. doi:10.3390/nu17172751

BibTeX
@article{Tzikos2025,
  author = {Tzikos, Georgios and Menni, Alexandra-Eleftheria and Theodorou, Helen and Chamalidou, Eleni and Theodorou, Ioannis M and Stavrou, George and Shrewsbury, Anne D and Amaniti, Aikaterini and Konsta, Anastasia and Tsetis, Joulia K and Grosomanidis, Vasileios and Kotzampassi, Katerina},
  title = {Beyond Analgesia: Psychobiotics as an Adjunctive Approach to Pain Management in Gastrointestinal Oncology—A Post Hoc Analysis from the ProDeCa Study},
  journal = {Nutrients},
  year = {2025},
  doi = {10.3390/nu17172751}
}
Kostenlos starten →